ScholarWorks@SOONCHUNHYANG UNIVERSITY: Kim, Yang Ki

Detailed Information

Kim, Yang Ki (김양기)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Venous thromboembolism:4||Bleeding:4||Pulmonary Embolism:4||Venous Thromboembolism:3||Pulmonary embolism:3||Thromboembolism:2||Asthma:2||Anticoagulation:2||Warfarin:2||폐색전증:2||항응고제:2||single nucleotide polymorphism:2||exacerbation:2||time in therapeutic range:2||venous thromboembolism:2||warfarin:2||Antioxidants:2||Anticoagulants:2||Cryptogenic Organizing Pneumonia:1||Death:1||Deep Vein Thrombosis:1||Direct oral anticoagulant:1||Disease Progression:1||Drugdrug interaction:1||Duration of anticoagulation:1||ELISA:1||Elderly:1||Extracelular SignalRegulated MAP Kinases:1||Extracorporeal Membrane Oxygenation:1||FEV1:1||Factor Xa:1||Fibrinolysisment:1||Fibrosis:1||Genomewide association study:1||Guideline:1||HRCT:1||Haplotype:1||Healthcare Personnel:1||Heparin:1||Idiopathic pulmonary fibrosis:1||Infection Control:1||Infectious Disease:1||Influenza:1||Inhaled corticosteroid:1||Intensive Care Units:1||International normalized ratio:1||Intracranial thrombosis:1||Isoniazid:1||Korea:1||Latent Tuberculosis:1||Latent tuberculosis infection:1||LowMolecularWeight Heparin:1||Lung Abscess:1||Lung Diseases:1||Macrolides:1||Medical Patients:1||Mesothelioma:1||Mice:1||Mortality:1||Mycobacterium:1||Mycobacterium tuberculosis:1||NLRP4:1||Neoplasm Metastasis:1||Nontuberculous mycobacteria:1||Obstructive:1||Operative:1||Oxidants:1||Ozone:1||POC INR test:1||PPM:1||Pandemic 2009 H1N1 influenza A:1||Pleuragenetic:1||Pleural Neoplasms:1||Pneumonia:1||Prevention:1||Privatepublic mix:1||Probrain natriuretic peptide:1||Prophylaxis of Venous Thromboembolism:1||PublicPrivate partnership:1||Pulmonary Disease:1||Quality control:1||RAR alpha:1||ROC curve:1||Radiography:1||Receptors:1||Recurrence:1||Recurrent Venous Thromboembolism:1||Rifampin:1||Risk Factors:1||Rivaroxaban:1||Singlenucleotide polymorphism:1||Smoking:1||Surgical Procedures:1||Survival Rate:1||TTR:1||Thoracic:1||Thrombin:1||Thrombolytic therapy:1||Thromboprophylaxis:1||Thymoma:1||Time in therapeutic range:1||Tomography:1||Tumor Suppressor Protein p53:1||Unprovoked:1||Venous thrombosis:1||Vitamin D:1||Vitamin K Antagonist:1||XRay Computed:1||anticoagulants:1||anticoagulation:1||asthma:1||atrial fibrillation:1||biologics:1||child:1||combined:1||complications:1||deep vein thrombosis:1||dosing algorithm:1||geneenvironment interaction:1||hemorrhage:1||heparin:1||inflammasome:1||innate immune response:1||interferon receptor 1:1||interferon receptor 2:1||intracranial hemorrhage:1||ischemic stroke:1||lowmolecularweight heparin:1||management:1||management of disease:1||medical history taking:1||neutrophilc inflammation:1||oral:1||pulmonary embolism:1||pulmonary eosinophilia:1||quality:1||remodeling:1||rest:1||risk factors:1||seasonal variation:1||seconadry stroke prevention:1||smoking:1||stroke/prevention:1||tobacco smoke pollution:1||tuberculosis:1||사망률:1||섬유화:1||응고인자Xa:1||정맥혈전증:1||질적관리:1||출혈:1||트롬빈:1||특발성 폐 섬유증:1||항응고제치료기간:1||헤파린:1||혈전용해치료:1||2DE:1||흡연:1||ALLC:1||Adrenal Cortex Hormones:1||Adverse drug reaction:1||Apical ballooning syndrome:1||Atrial fibrillation:1||Bridging:1||Bronchoalveolar lavage fluid:1||Creactive Protein:1||COPD:1||Calcitriol:1||Cardiac Ar:1||Cardiology:1||Chronic Obstructive:1||Cicatrix:1||Clarithromycin:1||Comorbidity:1||Contraceptives:1||

STATISTICS: Total View :1,226,925; Today View :529

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE